Effects of Ghrelin plasmid on growth performance and circulating GH, IGF-I, and SS in weaning piglets

ZHANG CAI; YANG WEN-YAN; GENG CHUN-YIN; LIU JIA-JIA; LI DE-LI; ZHENG XIN; YANG LIAN-YU

doi:10.56093/ijans.v82i10.24291

Authors

ZHANG CAI Henan University of Science and Technology, Luoyang 471000, PR China
YANG WEN-YAN Henan University of Science and Technology, Luoyang 471000, PR China
GENG CHUN-YIN Henan University of Science and Technology, Luoyang 471000, PR China
LIU JIA-JIA Henan University of Science and Technology, Luoyang 471000, PR China
LI DE-LI Henan University of Science and Technology, Luoyang 471000, PR China
ZHENG XIN Henan University of Science and Technology, Luoyang 471000, PR China
YANG LIAN-YU Henan University of Science and Technology, Luoyang 471000, PR China

https://doi.org/10.56093/ijans.v82i10.24291

Keywords:

ADG, Ghrelin plasmid, GH, IGF-I, SS

Abstract

The aim of this study was to investigate effects of ghrelin plasmid (PCI-ghrelin-28aa) administration on plasma growth hormone (GH), insulin-like growth factor-I (IGF- I), and somatostatin (SS) levels, and growth performance in weaning pigs. Number I Junmu weaning piglets (8), 45-day-old, were randomly placed into 2 groups. Pigs in treatment groups were injected intra-muscularly with 1.5 mg kg-1 of ghrelin plasmid and in the control group, same dose of elution buffer. On day 0, 7, 21, 35, 49, and 63, body weight, food intake, and the circulating levels of GH, IGF-I, and SS were measured. The results showed that ghrelin plasmid significantly increased average daily weight gain (ADG) by 10.45% at 21 to 35 days. There were no significant differences between the treatment and control groups for daily food intake. Feed gain ratio (F/G) for the ghrelin treatment group was significantly better than control at 21–35d and 0–63d. Serum GH concentrations were significantly higher than control at 35 and 49 days. IGF-I levels were higher at 7 to 35 days in treated piglets and then decreased to a value which was significantly lower than those of the controls at 63 days. SS increased by 14% at 35 days and by 50% at 63 days. Results indicated that Ghrelin plasmid increased ADG and F/ G, and regulated the levels of GH, IGF-I, and SS in piglets.

Downloads

Download data is not yet available.

Author Biographies

ZHANG CAI, Henan University of Science and Technology, Luoyang 471000, PR China
YANG WEN-YAN, Henan University of Science and Technology, Luoyang 471000, PR China
GENG CHUN-YIN, Henan University of Science and Technology, Luoyang 471000, PR China
LIU JIA-JIA, Henan University of Science and Technology, Luoyang 471000, PR China
LI DE-LI, Henan University of Science and Technology, Luoyang 471000, PR China
ZHENG XIN, Henan University of Science and Technology, Luoyang 471000, PR China
YANG LIAN-YU, Henan University of Science and Technology, Luoyang 471000, PR China

References

Dieguez C and Casanueva F F. 2000. Ghrelin: A step forward in the understanding of somatotroph cell function and growth regulation. European Journal of Endocrinology / European Federation of Endocrine Societies 142: 413–17.

Draghia-Akli R, Fiorotto M L and Hill L A. 1999. Nonclinical toxicology in support of licensure of gene therapies. Myogenic expression of an injectable protease resistant growth hormone- releasing hormone augments long term growth in pigs. Nature Biotechnology 17: 1179–83.

Draghia-Akli R, Li X G and Schwartz RJ. 1997. Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector. Nature Biotechnology 15: 1285–89.

Frederickson R M, Carter B J and Pilaro A M. 2003. Nonclinical toxicology in support of licensure of gene therapies. Molecular Therapy: Journal of the American Society of Gene Therapy 8: 8–10.

Gil-Campos M, Aguilera C M, Cañete R and Gil A. 2006. Ghrelin: a hormone regulating food intake and energy homeostasis. British Journal of Nutrition 96: 201–26.

Gonin P and Gaillard C.2004.Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development. Gene Therapy 11: S98– 08.

Hagstrom J E, Rybakova I N, Staeva T, Wolff J A and Ervasti J M. 1996. Nonnuclear DNA binding proteins in striated muscle. Biochemical and Molecular Medicine 58: 113–21.

Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H and Wakabayashi I. 2000. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141: 4797–4800.

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H and Kangawa K. 1999. Ghrelin is a novel growth-hormone-releasing acylated peptide from stomach. Nature 402: 656– 60.

Maura Arosio, Cristina L. Ronchi, Carlotta Gebbia, Vincenzo Cappiello, Paolo Beck-Peccoz and Maddalena Peracchi. 2003. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. Journal of Clinical Endocrinology and Metabolism 88: 701–04.

Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H and Kangawa K. 2002. vasodilatory effect of ghrelin, an endogenous peptide from the stomach. Journal of Cardiovascular Pharmacology 39: 779–83.

Peino R, Baldelli R, Rodriguez-Garcia J, Rodriguez-Segade S, Kojima M, Kangawa K, Arvat E, Ghigo E, Dieguez C and Casanueva F F. 2000. Ghrelin-induced growth hormone secretion in humans. European Journal of Endocrinology / European Federation of Endocrine Societies 143(6): R11–14.

Salfen B E, Carroll J A, Keisler D H and Strauch T A. 2004. Effects of exogenous ghrelin on feed intake, weight gain, behavior, and endocrine responses in weanling pigs. Journal of Animal Science 82: 1957–66.

Seoane LM, Lopez M, Tovar S, Casanueva F F, Senaris R and Dieguez C. 2003. Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus. Endocrinology 144: 544–51.

Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal M S, Shimbara T, Kawagoe T, Murakami N, Miyazato M, Kangawa K and Nakazato M. 2006. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 147: 2306–14.

Wolff J A, Malone R W, Williams P, Chong W, Acsadi G, Jani A and Felgner P L. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465–68.

Wren A M, Small C J, Ward H L, Murphy K G, Dakin C L, Taheri S, Kennedy A R, Roberts G H, Morgan D G, Ghatei M A and Bloom S R. 2000. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141: 4325–28.

Wu Xing-li , Tang Mao-yan , Ma Qiu-gang , Hu Xinxu and Ji Cheng. 2008. Effects of exogenous ghrelin on the behaviors and performance of weanling piglets. Asian-Australasian Journal of Animal Sciences 21: 861–67.

Yang Wen-yan, Yang Lian-yu and Geng Chun-yin. 2006. construction of eukaryotic expression recombinant plasmid of swine ghrelin gene and histogenic immunity examination in mice. Journal of Jaha Agricultural University 28: 667–70. (In Chinese.)

Zhang Yong , Yu-Jing Zhu , Zhe Li , Zhou An-Guo, Zhang Jing- Hai, Bardsley R G and Gibson S. 2008. Injection of porcine growth hormone releasing hormone gene plasmid in skeletal muscle increases piglets’ growth and whole body protein turnover. Livestock Science 115: 279–86.